NOBOX

{{Short description|Protein-coding gene in the species Homo sapiens}}

Homeobox protein NOBOX, also known as newborn ovary homeobox protein, is a protein that in humans is encoded by the NOBOX gene.{{cite web | title = Entrez Gene: NOBOX oogenesis homeobox| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=135935}}{{cite journal | vauthors = Suzumori N, Yan C, Matzuk MM, Rajkovic A | title = Nobox is a homeobox-encoding gene preferentially expressed in primordial and growing oocytes | journal = Mechanisms of Development | volume = 111 | issue = 1–2 | pages = 137–41 | date = February 2002 | pmid = 11804785 | doi = 10.1016/S0925-4773(01)00620-7 | s2cid = 7205659 | doi-access = }}{{cite journal | vauthors = Huntriss J, Hinkins M, Picton HM | title = cDNA cloning and expression of the human NOBOX gene in oocytes and ovarian follicles | journal = Molecular Human Reproduction | volume = 12 | issue = 5 | pages = 283–9 | date = May 2006 | pmid = 16597639 | doi = 10.1093/molehr/gal035 | doi-access = }} The official symbol (NOBOX) and the official full name (NOBOX oogenesis homeobox) are maintained by the HGNC. The NOBOX gene is conserved in chimpanzee, Rhesus monkey, cow, mouse, and rat. There are 175 organisms that have orthologs with human gene NOBOX. It is capable of regulating other genes that are important in the development of follicles. Follicles do not develop and oocytes decrease in its absence which lead to infertility.

Discovery

NOBOX is an in silico subtraction discovery when Suzumori et al. searched for novel genes involved in early mammalian folliculogenesis in 2002. It is one of the several genes that appeared in the search in expressed sequence tag (EST) databases of mouse. It was then cloned and characterised for its genomic structure.

Gene location

The human NOBOX is located in chromosome 7q35 while the mouse NOBOX is in proximal chromosome 6.

Protein structure

The human NOBOX is a 14 kb protein and encoded by 8 exons. It has a proline rich C terminus and contains putative SH3 and WW domains.{{cite journal | vauthors = Kay BK, Williamson MP, Sudol M | title = The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains | journal = FASEB Journal | volume = 14 | issue = 2 | pages = 231–41 | date = February 2000 | pmid = 10657980 | doi=10.1096/fasebj.14.2.231| doi-access = free | s2cid = 10475561 }} This C terminus is believed to be critical in its transcriptional activities when bound to oocyte-specific genes.{{cite journal | vauthors = Choi Y, Rajkovic A | title = Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters | journal = The Journal of Biological Chemistry | volume = 281 | issue = 47 | pages = 35747–56 | date = November 2006 | pmid = 16997917 | doi = 10.1074/jbc.M604008200 | doi-access = free }} NOBOX belongs to the family of proteins that contains homeodomain. Homeodomain is a stretch of 32 specific amino acids in primates downstream the NOBOX Arg303 residue and is very well-conserved among the species. It contains an asparagine residue at position 51 which is important for its interactions with DNA base pairs.{{cite journal|vauthors=Laughon A|date=December 1991|title=DNA binding specificity of homeodomains|journal=Biochemistry|language=EN|volume=30|issue=48|pages=11357–67|doi=10.1021/bi00112a001|pmid=1742275}}{{cite journal | vauthors = Fraenkel E, Pabo CO | title = Comparison of X-ray and NMR structures for the Antennapedia homeodomain-DNA complex | journal = Nature Structural Biology | volume = 5 | issue = 8 | pages = 692–7 | date = August 1998 | pmid = 9699632 | doi = 10.1038/1382 | s2cid = 24233895 }}{{cite journal | vauthors = Kissinger CR, Liu BS, Martin-Blanco E, Kornberg TB, Pabo CO | title = Crystal structure of an engrailed homeodomain-DNA complex at 2.8 A resolution: a framework for understanding homeodomain-DNA interactions | journal = Cell | volume = 63 | issue = 3 | pages = 579–90 | date = November 1990 | pmid = 1977522 | doi = 10.1016/0092-8674(90)90453-l | s2cid = 1678791 | doi-access = free }}

Function

NOBOX is a homeobox gene that is preferentially expressed in oocytes. In mice, it is essential for folliculogenesis and regulation of oocyte-specific genes. Regulation of these oocyte-specific genes is thru direct binding of NOBOX to its promoter regions via the specific consensus sequences, the NOBOX DNA binding elements (NBEs). There are three NBEs that have been identified: 5'-TAATTG-3', 5'-TAGTTG-3', and 5'-TAATTA-3'. Knockout study of NOBOX against wild-type ovaries in newborn female mice revealed that 74% (28/38 genes) were downregulated more than 5-fold and 15% (5/33 genes) were upregulated more than 5-fold.{{cite journal | vauthors = Choi Y, Qin Y, Berger MF, Ballow DJ, Bulyk ML, Rajkovic A | title = Microarray analyses of newborn mouse ovaries lacking Nobox | journal = Biology of Reproduction | volume = 77 | issue = 2 | pages = 312–9 | date = August 2007 | pmid = 17494914 | doi = 10.1095/biolreprod.107.060459 | doi-access = free }} However, microRNA population is not affected by NOBOX in newborn ovaries. NOBOX also plays an important role in the suppression of male-determining genes such as Dmrt1. Its deficiency can cause rapid loss of postnatal oocytes and during its absence in female mice, follicles are replaced by fibrous tissue. Recently, a new role of NOBOX in controlling the G2/M arrest was discovered.

Mutations and clinical significance

A mutation in the NOBOX gene is associated with premature ovarian failure (POF), also known as premature ovarian insufficiency (POI).{{cite journal | vauthors = Qin Y, Choi Y, Zhao H, Simpson JL, Chen ZJ, Rajkovic A | title = NOBOX homeobox mutation causes premature ovarian failure | journal = American Journal of Human Genetics | volume = 81 | issue = 3 | pages = 576–81 | date = September 2007 | pmid = 17701902 | pmc = 1950834 | doi = 10.1086/519496 }} It is a condition which ovaries loss its normal function before the age of 40. It is a heritable disease in up to 30% of patients which is characterised by secondary infertility, amenorrhea, hypoestrogenism, and elevated follicle-stimulating hormone levels in the serum (FSH>40IU/liter).{{cite journal | vauthors = Vegetti W, Grazia Tibiletti M, Testa G, Alagna F, Castoldi E, Taborelli M, Motta T, Bolis PF, Dalprà L, Crosignani PG | title = Inheritance in idiopathic premature ovarian failure: analysis of 71 cases | journal = Human Reproduction | volume = 13 | issue = 7 | pages = 1796–800 | date = July 1998 | pmid = 9740426 | doi=10.1093/humrep/13.7.1796| doi-access = free }}{{cite journal | vauthors = Coulam CB, Adamson SC, Annegers JF | title = Incidence of premature ovarian failure | journal = Obstetrics and Gynecology | volume = 67 | issue = 4 | pages = 604–6 | date = April 1986 | pmid = 3960433 }} It affects ≈1% of women below 40 years old.{{cite journal | vauthors = De Vos M, Devroey P, Fauser BC | title = Primary ovarian insufficiency | journal = Lancet | volume = 376 | issue = 9744 | pages = 911–21 | date = September 2010 | pmid = 20708256 | doi = 10.1016/S0140-6736(10)60355-8 | s2cid = 19404756 }} A study conducted on 96 white women with POF revealed one case of heterozygous mutation in the NOBOX homeodomain, p.Arg355His, in one patient. This mutation was absent in the control population and significantly disrupts the binding of NOBOX to the NBE. Arg355 is critical to DNA binding and is conserved in the homeodomain of the NOBOX from zebrafish to humans. Moreover, its significant negative effect suggests that NOBOX homeodomain may function as a dimer but its rare occurrence suggests a low contribution to POF. Further investigations on POF were conducted on Caucasian, African, Chinese, and Japanese women diagnosed with POF. Several NOBOX loss-of-function mutations were observed in Caucasian and African women accounting to 6.2%, 5.6% and 6.4%.{{cite journal | vauthors = Bouilly J, Bachelot A, Broutin I, Touraine P, Binart N | title = Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort | journal = Human Mutation | volume = 32 | issue = 10 | pages = 1108–13 | date = October 2011 | pmid = 21837770 | doi = 10.1002/humu.21543 | s2cid = 30861702 | doi-access = free }}{{cite journal | vauthors = Bouilly J, Roucher-Boulez F, Gompel A, Bry-Gauillard H, Azibi K, Beldjord C, Dodé C, Bouligand J, Mantel AG, Hécart AC, Delemer B, Young J, Binart N | title = New NOBOX mutations identified in a large cohort of women with primary ovarian insufficiency decrease KIT-L expression | journal = The Journal of Clinical Endocrinology and Metabolism | volume = 100 | issue = 3 | pages = 994–1001 | date = March 2015 | pmid = 25514101 | doi = 10.1210/jc.2014-2761 | doi-access = free }}{{cite journal | vauthors = Bouali N, Francou B, Bouligand J, Lakhal B, Malek I, Kammoun M, Warszawski J, Mougou S, Saad A, Guiochon-Mantel A | title = NOBOX is a strong autosomal candidate gene in Tunisian patients with primary ovarian insufficiency | journal = Clinical Genetics | volume = 89 | issue = 5 | pages = 608–13 | date = May 2016 | pmid = 26848058 | doi = 10.1111/cge.12750 | s2cid = 25656158 }} These results suggest that NOBOX gene is a strong autosomal candidate for POF and its genetic mechanism involves haploinsufficiency. However, these mutations were not found in Chinese and Japanese women making it a less common explanation for POF in the region.{{cite journal | vauthors = Qin Y, Shi Y, Zhao Y, Carson SA, Simpson JL, Chen ZJ | title = Mutation analysis of NOBOX homeodomain in Chinese women with premature ovarian failure | journal = Fertility and Sterility | volume = 91 | issue = 4 Suppl | pages = 1507–9 | date = April 2009 | pmid = 18930203 | doi = 10.1016/j.fertnstert.2008.08.020 | doi-access = free }}{{cite journal | vauthors = Zhao XX, Suzumori N, Yamaguchi M, Suzumori K | title = Mutational analysis of the homeobox region of the human NOBOX gene in Japanese women who exhibit premature ovarian failure | language = en | journal = Fertility and Sterility | volume = 83 | issue = 6 | pages = 1843–4 | date = June 2005 | pmid = 15950662 | doi = 10.1016/j.fertnstert.2004.12.031 | doi-access = free }}

The POF syndrome is a highly heterogenous clinical disorder but a recent study showed the first homozygous mutation associated with NOBOX loss-of-function.{{cite journal | vauthors = Li L, Wang B, Zhang W, Chen B, Luo M, Wang J, Wang X, Cao Y, Kee K | title = A homozygous NOBOX truncating variant causes defective transcriptional activation and leads to primary ovarian insufficiency | journal = Human Reproduction | volume = 32 | issue = 1 | pages = 248–255 | date = January 2017 | pmid = 27836978 | doi = 10.1093/humrep/dew271 | doi-access = free }} One patient out of 96 population diagnosed with POF in China was found with one novel homozygous truncating variant in the NOBOX gene. This truncated variant caused a defective transcriptional activation of GDF9, a well-known target of NOBOX, which led to the lost ability of NOBOX to induce G2/M arrest. This finding disagrees that mutation is a less common explanation for POF in Asian population.

Understanding the mutations in NOBOX homeodomain is important to researchers and clinicians to develop diagnostic and therapeutic approaches for POF such as genetic control of mammalian reproductive life-span, regulation of fertility, and generation of mature eggs in the lab.

Interactions

GDF9{{cite journal | vauthors = Bayne RA, Kinnell HL, Coutts SM, He J, Childs AJ, Anderson RA | title = GDF9 is transiently expressed in oocytes before follicle formation in the human fetal ovary and is regulated by a novel NOBOX transcript | journal = PLOS ONE | volume = 10 | issue = 3 | pages = e0119819 | date = 2015-03-19 | pmid = 25790371 | pmc = 4366263 | doi = 10.1371/journal.pone.0119819 | bibcode = 2015PLoSO..1019819B | doi-access = free }}
POU5F1{{cite journal | vauthors = Rajkovic A, Pangas SA, Ballow D, Suzumori N, Matzuk MM | title = NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression | journal = Science | volume = 305 | issue = 5687 | pages = 1157–9 | date = August 2004 | pmid = 15326356 | doi = 10.1126/science.1099755 | bibcode = 2004Sci...305.1157R | s2cid = 26646489 }}
DNMT10
FOXL2{{cite journal | vauthors = Bouilly J, Veitia RA, Binart N | title = NOBOX is a key FOXL2 partner involved in ovarian folliculogenesis | journal = Journal of Molecular Cell Biology | volume = 6 | issue = 2 | pages = 175–7 | date = April 2014 | pmid = 24620032 | doi = 10.1093/jmcb/mju006 | s2cid = 16608843 | doi-access = free }}
FIGLA
RSPO2{{cite journal | vauthors = Bouilly J, Beau I, Barraud S, Bernard V, Delemer B, Young J, Binart N | title = R-spondin2, a novel target of NOBOX: identification of variants in a cohort of women with primary ovarian insufficiency | journal = Journal of Ovarian Research | volume = 10 | issue = 1 | pages = 51 | date = July 2017 | pmid = 28743298 | pmc = 5526297 | doi = 10.1186/s13048-017-0345-0 | doi-access = free }}
DMRT1